A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer

Gynecologic Oncology
Pamela T SolimanKaren H Lu

Abstract

Sentinel lymph node (SLN) mapping continues to evolve in the surgical staging of endometrial cancer (EC). The purpose of this trial was to identify the sensitivity, false negative rate (FNR) and FN predictive value (FNPV) of SLN compared to complete pelvic and para-aortic lymphadenectomy (LAD) in women with high-risk EC. Women with high-risk EC (grade 3, serous, clear cell, carcinosarcoma) were enrolled in this prospective surgical trial. All patients underwent preoperative PET/CT and intraoperative SLN biopsy followed by LAD. Patients with peritoneal disease on imaging or at the time of surgery were excluded. Patients were evaluable if SLN was attempted and complete LAD was performed. 123 patients were enrolled between 4/13 and 5/16; 101 were evaluable. At least 1 SLN was identified in 89% (90); bilateral detection 58%, unilateral pelvic 40%, para-aortic only 2%. Indocyanine green was used in 61%, blue dye in 28%, and blue dye and technetium in 11%. Twenty-three pts. (23%) had ≥1 positive node. In 20/23, ≥1 SLN was identified and in 19/20 the SLN was positive. Only 1 patient had bilateral negative SLN and positive non-SLNs on final pathology. Overall, sensitivity of SLN was 95% (19/20), FNR was 5% (1/20) and FNPV was 1.4% (1/7...Continue Reading

Associated Clinical Trials

Citations

Aug 21, 2018·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Shinichi TogamiHiroaki Kobayashi
Oct 12, 2018·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Frédéric AmantCarien L Creutzberg
Jan 15, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J A HaroldW H Bradley
Feb 13, 2019·Archives of Gynecology and Obstetrics·Tian WangZhengchen Guo
Oct 16, 2018·Minerva ginecologica·Andrea PapadiaMichael D Mueller
Mar 13, 2019·International Journal of Molecular Sciences·Erin A SalinasJesus Gonzalez Bosquet
Jan 9, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Fabio MartinelliFrancesco Raspagliesi
Jan 9, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Katherine I StewartPamela T Soliman
Jan 30, 2020·Journal of Surgical Oncology·Seongmin KimNak Woo Lee
Jun 7, 2019·Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy·Massimo FranchiFabio Ghezzi
Sep 2, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Giulio SozziVito Chiantera
Feb 23, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Cinzia CrivellaroElisabetta De Bernardi
Mar 23, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Shinichi TogamiHiroaki Kobayashi
Apr 25, 2018·Journal of Cancer Research and Clinical Oncology·Andrea PapadiaMichael D Mueller
Mar 23, 2018·Cancer Investigation·Natalia R Gómez-HidalgoJason D Wright
Mar 20, 2019·Journal of Gynecologic Oncology·Laura Moulton ChambersChad M Michener
Aug 14, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carien L CreutzbergGini F Fleming
Nov 7, 2019·Annals of Surgical Oncology·Glauco BaiocchiLouise De Brot
Aug 21, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Agnieszka RychlikPluvio J Coronado Martín
Nov 22, 2018·Journal of Cancer Research and Clinical Oncology·Maria Luisa GasparriMichael D Mueller
Sep 13, 2018·Journal of Gynecologic Oncology·Giorgio BoganiAndrea Mariani
Nov 14, 2018·Current Oncology Reports·C Reneé Franklin, Edward J Tanner
Dec 20, 2019·Clinical Obstetrics and Gynecology·Khaled GhoniemAndrea Mariani
Jan 30, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Yoo-Na KimSang Wun Kim
Jul 8, 2020·Journal of Clinical Medicine·Virginia García PinedaIgnacio Zapardiel
Mar 4, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Michael Frumovitz, Alessandro Buda
Jul 17, 2018·Archives of Gynecology and Obstetrics·Lijun Wang, Fang Liu
Feb 4, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Emma C Rossi
Oct 28, 2019·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Innocenza PalaiaPierluigi Benedetti Panici
Jun 25, 2019·F1000Research·Lindsey M Charo, Steven C Plaxe
May 7, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·M RabykM Hruby
Oct 24, 2017·Annals of Surgical Oncology·Glauco BaiocchiAlexandre Andre Balieiro Anastacio da Costa
Jan 6, 2021·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Nicole ConcinCarien L Creutzberg
Nov 18, 2020·Minerva medica·Pier C ZorzatoStefano Uccella
Nov 19, 2020·The New England Journal of Medicine·Karen H Lu, Russell R Broaddus
Feb 1, 2021·Gynecologic Oncology·Chad A HamiltonWilliam M Burke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.